Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

McKesson
Medtronic
Colorcon
Harvard Business School
Boehringer Ingelheim
Baxter

Last Updated: November 19, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR FINASTERIDE

See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Finasteride

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00002651 Hormone Therapy in Treating Men With Stage IV Prostate Cancer Unknown status Cancer and Leukemia Group B Phase 3 1995-05-01 RATIONALE: Testosterone can stimulate the growth of prostate cancer cells. Hormone therapy may be effective treatment for prostate cancer. It is not yet known which regimen of hormone therapy is most effective for stage IV prostate cancer. PURPOSE: This randomized phase III trial is studying two different regimens of hormone therapy and comparing how well they work in treating men with stage IV prostate cancer.
NCT00002651 Hormone Therapy in Treating Men With Stage IV Prostate Cancer Unknown status Eastern Cooperative Oncology Group Phase 3 1995-05-01 RATIONALE: Testosterone can stimulate the growth of prostate cancer cells. Hormone therapy may be effective treatment for prostate cancer. It is not yet known which regimen of hormone therapy is most effective for stage IV prostate cancer. PURPOSE: This randomized phase III trial is studying two different regimens of hormone therapy and comparing how well they work in treating men with stage IV prostate cancer.
NCT00002651 Hormone Therapy in Treating Men With Stage IV Prostate Cancer Unknown status European Organisation for Research and Treatment of Cancer - EORTC Phase 3 1995-05-01 RATIONALE: Testosterone can stimulate the growth of prostate cancer cells. Hormone therapy may be effective treatment for prostate cancer. It is not yet known which regimen of hormone therapy is most effective for stage IV prostate cancer. PURPOSE: This randomized phase III trial is studying two different regimens of hormone therapy and comparing how well they work in treating men with stage IV prostate cancer.
NCT00002651 Hormone Therapy in Treating Men With Stage IV Prostate Cancer Unknown status National Cancer Institute (NCI) Phase 3 1995-05-01 RATIONALE: Testosterone can stimulate the growth of prostate cancer cells. Hormone therapy may be effective treatment for prostate cancer. It is not yet known which regimen of hormone therapy is most effective for stage IV prostate cancer. PURPOSE: This randomized phase III trial is studying two different regimens of hormone therapy and comparing how well they work in treating men with stage IV prostate cancer.
NCT00002651 Hormone Therapy in Treating Men With Stage IV Prostate Cancer Unknown status NCIC Clinical Trials Group Phase 3 1995-05-01 RATIONALE: Testosterone can stimulate the growth of prostate cancer cells. Hormone therapy may be effective treatment for prostate cancer. It is not yet known which regimen of hormone therapy is most effective for stage IV prostate cancer. PURPOSE: This randomized phase III trial is studying two different regimens of hormone therapy and comparing how well they work in treating men with stage IV prostate cancer.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Finasteride

Condition Name

Condition Name for Finasteride
Intervention Trials
Benign Prostatic Hyperplasia 10
Healthy 10
Androgenetic Alopecia 6
Prostatic Hyperplasia 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Finasteride
Intervention Trials
Prostatic Hyperplasia 21
Hyperplasia 19
Alopecia 10
Alopecia Areata 9
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Finasteride

Trials by Country

Trials by Country for Finasteride
Location Trials
United States 116
Canada 19
Korea, Republic of 8
Mexico 6
Argentina 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Finasteride
Location Trials
Texas 10
Florida 8
California 7
Illinois 6
New York 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Finasteride

Clinical Trial Phase

Clinical Trial Phase for Finasteride
Clinical Trial Phase Trials
Phase 4 7
Phase 3 16
Phase 2 15
[disabled in preview] 20
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Finasteride
Clinical Trial Phase Trials
Completed 39
Recruiting 6
Terminated 5
[disabled in preview] 8
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Finasteride

Sponsor Name

Sponsor Name for Finasteride
Sponsor Trials
GlaxoSmithKline 5
Dr. Reddy's Laboratories Limited 4
Merck Sharp & Dohme Corp. 4
[disabled in preview] 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Finasteride
Sponsor Trials
Industry 42
Other 39
NIH 16
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Dow
Boehringer Ingelheim
Baxter
Express Scripts
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.